Drug intelligence / Profile preview

(4e)-4-aminohex-4-enoic acid

Development stage
Unknown
Modality
Small Molecules
01

Overview

(4e)-4-Aminohex-4-Enoic Acid is a synthetic gamma amino acid derivative with the molecular formula C6H11NO2 and a molecular weight of approximately 129.16 g/mol[1][2][8]. It is classified as an experimental small molecule compound and has not been approved for clinical use in any country[1]. The compound acts as an inhibitor of the enzyme 4‑aminobutyrate aminotransferase, mitochondrial (also known as GABA transaminase or GABA-T), which plays a key role in the catabolism of gamma‑aminobutyric acid (GABA), an important inhibitory neurotransmitter in the central nervous system[3][7]. By inhibiting this enzyme, compounds like (4e)-4-Aminohex‑4‑Enoic Acid can potentially increase brain GABA levels. This mechanism is similar to that of certain antiepileptic drugs targeting GABA metabolism, though there are no indications that this specific compound has advanced beyond experimental status or entered clinical trials for epilepsy or other neurological disorders[1][3].

Other names
(E)-4-aminohex-4-enoic acid*E*)-4-aminohex-4-enoic acid4-Hexenoic acid, 4-amino-, (4E)-GEG
02

Targets

ABAT (4-aminobutyrate aminotransferase)

Beyond the preview

Go deeper on (4e)-4-aminohex-4-enoic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (4e)-4-aminohex-4-enoic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call